Pelthos Therapeutics Inc. PTHS
22.19
(0.21)
(0.94%)
as of 25 Sep
- Market cap
- $85.8M
- P/E
- 0.0×
Follow PTHS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(82.99%) | (239.55%) | (881.53%) | 2,161.07% | |
| (36.68%) | (65.75%) | (90.81%) | (125.04%) | ||
ROIC |
(31.61%) | (38.76%) | (51.99%) | (82.34%) | |
Return on Tangible Assets |
(67.05%) | (117.07%) | (122.76%) | (214.49%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 122.07 | |
Free Cash Flow per Share |
(5.56) | (12.01) | (10.68) | (12.03) | |
Free Cash Flow |
(17.01) | (22.59) | (35.38) | (42.60) | |
Capital Expenditures |
— | — | (0.29) | (0.29) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(23.46%) | (25.57%) | (29.99%) | (45.50%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 1.71 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 230.43 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 845.35 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 3.01% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 200.61% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 21.31% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.72 | 0.52 | 0.53 | 0.49 | |
Depreciation/Fixed assets |
0.15 | 0.27 | 0.46 | 0.65 | |
Capex/Depreciation |
0.00 | 0.00 | (0.07) | (0.05) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 12.23 | |
Operating CF per Share |
(5.56) | (12.01) | (10.59) | (11.95) | |
Capex per Share |
0.00 | 0.00 | (0.09) | (0.08) | |
Capex to Sales |
— | — | 0.00 | 0.01 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (199.50%) |
Columns are period end dates